BR112012007979A2 - moduladores de gpr40 de pirrolidina - Google Patents
moduladores de gpr40 de pirrolidinaInfo
- Publication number
- BR112012007979A2 BR112012007979A2 BR112012007979A BR112012007979A BR112012007979A2 BR 112012007979 A2 BR112012007979 A2 BR 112012007979A2 BR 112012007979 A BR112012007979 A BR 112012007979A BR 112012007979 A BR112012007979 A BR 112012007979A BR 112012007979 A2 BR112012007979 A2 BR 112012007979A2
- Authority
- BR
- Brazil
- Prior art keywords
- gpr40 modulators
- pyrrolidine
- modulators
- pyrrolidine gpr40
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
moduladores de gpr40 de pirrolidina a presente de invenção refere-se a compostos de fórmula (i): ou um estereoisônero, ou um sal farmaceuticamente aceitável dos mesmos , em que todas as variáveis são como aqui definidas. estes compostos são moduladores do receptor acoplado a proteína ggpr40 que podem ser usados como medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24889609P | 2009-10-06 | 2009-10-06 | |
PCT/US2010/051389 WO2011044073A1 (en) | 2009-10-06 | 2010-10-05 | Pyrrolidine gpr40 modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012007979A2 true BR112012007979A2 (pt) | 2016-03-29 |
Family
ID=43242297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012007979A BR112012007979A2 (pt) | 2009-10-06 | 2010-10-05 | moduladores de gpr40 de pirrolidina |
Country Status (13)
Country | Link |
---|---|
US (1) | US8288404B2 (pt) |
EP (1) | EP2486005B1 (pt) |
JP (1) | JP2013506714A (pt) |
KR (1) | KR20120104534A (pt) |
CN (1) | CN102639495A (pt) |
AR (1) | AR078542A1 (pt) |
AU (1) | AU2010303670A1 (pt) |
BR (1) | BR112012007979A2 (pt) |
CA (1) | CA2777041A1 (pt) |
MX (1) | MX2012003389A (pt) |
RU (1) | RU2012118504A (pt) |
TW (1) | TW201116510A (pt) |
WO (1) | WO2011044073A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103402986A (zh) | 2010-11-24 | 2013-11-20 | 阿勒根公司 | S1p受体的调节剂 |
CN104780915A (zh) | 2012-07-11 | 2015-07-15 | 埃尔舍利克斯治疗公司 | 包含他汀、双胍和用于减小心脏代谢风险的其它药剂的组合物 |
KR101942752B1 (ko) * | 2012-11-05 | 2019-01-28 | 주식회사 엘지화학 | Gpr120 효능제로서의 티오아릴 유도체 |
WO2014078611A1 (en) | 2012-11-16 | 2014-05-22 | Bristol-Myers Squibb Company | Dihydropyrazole gpr40 modulators |
CN105121426B (zh) * | 2012-11-16 | 2017-03-29 | 百时美施贵宝公司 | 吡咯烷gpr40调节剂 |
KR20150082617A (ko) * | 2012-11-16 | 2015-07-15 | 브리스톨-마이어스 스큅 컴퍼니 | 디히드로피라졸 gpr40 조절제 |
BR112015010779A2 (pt) | 2012-11-16 | 2017-07-11 | Bristol Myers Squibb Co | moduladores de di-hidropirazol gpr40 |
US8962660B2 (en) | 2013-03-14 | 2015-02-24 | Bristol-Myers Squibb Company | Oxabicyclo [2.2.2] acid GPR120 modulators |
CA2914132A1 (en) | 2013-06-21 | 2014-12-24 | Lupin Limited | Substituted heterocyclic compounds as crac modulators |
US9790231B2 (en) | 2013-06-24 | 2017-10-17 | Lupin Limited | Chromane and chromene derivatives and their use as CRAC modulators |
KR20160077213A (ko) | 2013-11-14 | 2016-07-01 | 카딜라 핼쓰캐어 리미티드 | 새로운 헤테로시클릭 화합물 |
EP3080097B1 (en) | 2013-12-13 | 2018-04-18 | F.Hoffmann-La Roche Ag | Inhibitors of bruton's tyrosine kinase |
CA2948175A1 (en) * | 2014-05-07 | 2015-11-12 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes |
DK3140296T3 (en) * | 2014-05-07 | 2018-07-23 | Bristol Myers Squibb Co | PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES |
US10301260B2 (en) * | 2014-05-07 | 2019-05-28 | Bristol-Myers Squibb Company | Pyrrolidine GPR40 modulators |
CN110023298B (zh) * | 2016-11-24 | 2022-12-16 | 浙江迈同生物医药有限公司 | 异柠檬酸脱氢酶(idh)抑制剂 |
AU2019222644B2 (en) | 2018-02-13 | 2021-04-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
JP7268049B2 (ja) | 2018-03-08 | 2023-05-02 | インサイト・コーポレイション | PI3K-γ阻害剤としてのアミノピラジンジオール化合物 |
US10899735B2 (en) | 2018-04-19 | 2021-01-26 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
JP7105359B2 (ja) | 2018-07-13 | 2022-07-22 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
AU2019366355B2 (en) | 2018-10-24 | 2022-10-13 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
CN110041269A (zh) * | 2019-05-16 | 2019-07-23 | 海门瑞一医药科技有限公司 | 一种2-氯-5-羟基嘧啶的制备方法 |
CN111253223A (zh) * | 2020-03-20 | 2020-06-09 | 重庆医科大学 | 一类大位阻三芳基甲烷衍生物及其合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4579681B2 (ja) | 2002-07-09 | 2010-11-10 | ブリストル−マイヤーズ スクイブ カンパニー | 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法 |
DE10309929B4 (de) * | 2003-03-07 | 2006-02-23 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
US7501440B2 (en) | 2003-03-07 | 2009-03-10 | Sanofi-Aventis Deutschland Gmbh | Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use |
EP2064193A1 (en) | 2006-09-07 | 2009-06-03 | Amgen, Inc | Heterocyclic gpr40 modulators |
-
2010
- 2010-10-05 AU AU2010303670A patent/AU2010303670A1/en not_active Abandoned
- 2010-10-05 JP JP2012533240A patent/JP2013506714A/ja active Pending
- 2010-10-05 WO PCT/US2010/051389 patent/WO2011044073A1/en active Application Filing
- 2010-10-05 US US12/897,913 patent/US8288404B2/en active Active
- 2010-10-05 MX MX2012003389A patent/MX2012003389A/es not_active Application Discontinuation
- 2010-10-05 CN CN2010800552581A patent/CN102639495A/zh active Pending
- 2010-10-05 EP EP10763955.1A patent/EP2486005B1/en not_active Not-in-force
- 2010-10-05 KR KR1020127011617A patent/KR20120104534A/ko not_active Application Discontinuation
- 2010-10-05 RU RU2012118504/04A patent/RU2012118504A/ru unknown
- 2010-10-05 BR BR112012007979A patent/BR112012007979A2/pt not_active Application Discontinuation
- 2010-10-05 CA CA2777041A patent/CA2777041A1/en not_active Abandoned
- 2010-10-06 AR ARP100103635A patent/AR078542A1/es not_active Application Discontinuation
- 2010-10-06 TW TW099134095A patent/TW201116510A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011044073A1 (en) | 2011-04-14 |
EP2486005B1 (en) | 2014-06-18 |
US20110082165A1 (en) | 2011-04-07 |
AU2010303670A1 (en) | 2012-03-29 |
KR20120104534A (ko) | 2012-09-21 |
CA2777041A1 (en) | 2011-04-14 |
RU2012118504A (ru) | 2013-11-20 |
JP2013506714A (ja) | 2013-02-28 |
MX2012003389A (es) | 2012-04-10 |
TW201116510A (en) | 2011-05-16 |
US8288404B2 (en) | 2012-10-16 |
CN102639495A (zh) | 2012-08-15 |
AR078542A1 (es) | 2011-11-16 |
EP2486005A1 (en) | 2012-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012007979A2 (pt) | moduladores de gpr40 de pirrolidina | |
BR112015010779A2 (pt) | moduladores de di-hidropirazol gpr40 | |
BR112015011031A2 (pt) | moduladores de grp40 de di-hidropirazol | |
EA201590953A1 (ru) | Пирролидиновые модуляторы gpr40 | |
BR112015010791A2 (pt) | moduladores de gpr40 de di-hidropirazol | |
BR112016009630A8 (pt) | receptores de farnesoide x, seus usos, composição farmacêutica, e combinação | |
BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
BR112015021596A2 (pt) | moduladores de gpr120 de ácido oxabiciclo[2.2.2] | |
JO3297B1 (ar) | تركيبات و طرق لتعديل fxr | |
CA2797033C (en) | Highly active polypeptides and methods of making and using the same | |
BR112012026950A2 (pt) | composto, e, uso de um composto | |
EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
BR112015032921A8 (pt) | compostos de benzofuranila e benzoxazolila substituídos e utilizações dos mesmos | |
BR112014010576A2 (pt) | inibidores de neprilisina | |
BR112014018027A8 (pt) | Composto, composição farmacêutica e usos dos mesmos e métodos para aumentar a inclusão de éxon 7 de ame2 em rnam que é transcrito a partir do gene ame2 e para aumentar a quantidade de proteína smn | |
BR112015021386A2 (pt) | moduladores de ácido biciclo [2.2.2] gpr120 | |
BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
EA201170198A1 (ru) | Фармацевтические композиции, содержащие лиганды рецептора дофамина | |
BRPI0908421B8 (pt) | solução estável de um composto farmacêutico | |
BR112014013228A2 (pt) | arila di-hidropiridinona e piperidinona como inibidores de mgat2 | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
BR112015021990A2 (pt) | moduladores de gpr120 de ácido biciclo [2.2.1] | |
BR112016024936A2 (pt) | moduladores de gpr40 à base de pirrolidina para tratamento de doenças como diabetes | |
BR112012025590A2 (pt) | análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119 | |
BRPI1014802B8 (pt) | profármacos de triptolida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |